Groundbreaking Neurotech.
Groundbreaking Neurotech.
Groundbreaking Neurotech.
Synchron, a neurotechnology leader, is developing the Stentrode™: a revolutionary Brain-Computer Interface (BCI) implanted via blood vessels, eliminating the need for open-brain surgery.
Synchron, a neurotechnology leader, is developing the Stentrode™: a revolutionary Brain-Computer Interface (BCI) implanted via blood vessels, eliminating the need for open-brain surgery.
*Reference https://synchron.com/
*Reference https://synchron.com/
Groundbreaking Neurotech.
Synchron, a neurotechnology leader, is developing the Stentrode™: a revolutionary Brain-Computer Interface (BCI) implanted via blood vessels, eliminating the need for open-brain surgery.
*Reference https://synchron.com/
ACQUANDAS Enables Synchron's BCI Breakthrough
Client: Synchron. Sector: MedTech (Neurotechnology / BCI).
Client: Synchron. Sector: MedTech (Neurotechnology / BCI).
Client: Synchron. Sector: MedTech (Neurotechnology / BCI).
The Challenge: Minimally Invasive BCI's
Synchron, a leader in neurotechnology, is developing the Stentrode™—a revolutionary Brain-Computer Interface (BCI) implanted via blood vessels, eliminating the need for open-brain surgery. This less invasive approach offers new hope for individuals with severe paralysis.
To realize this breakthrough, Synchron required components that were exceptionally miniaturized, flexible, and biocompatible. Traditional manufacturing methods fell short of producing the self-expanding bioelectronic structures needed to navigate delicate neural pathways and transmit brain signals safely. Synchron needed a partner capable of transforming the impossible into reality.
Synchron, a leader in neurotechnology, is developing the Stentrode™—a revolutionary Brain-Computer Interface (BCI) implanted via blood vessels, eliminating the need for open-brain surgery. This less invasive approach offers new hope for individuals with severe paralysis.
To realize this breakthrough, Synchron required components that were exceptionally miniaturized, flexible, and biocompatible. Traditional manufacturing methods fell short of producing the self-expanding bioelectronic structures needed to navigate delicate neural pathways and transmit brain signals safely. Synchron needed a partner capable of transforming the impossible into reality.
Synchron, a leader in neurotechnology, is developing the Stentrode™—a revolutionary Brain-Computer Interface (BCI) implanted via blood vessels, eliminating the need for open-brain surgery. This less invasive approach offers new hope for individuals with severe paralysis.
To realize this breakthrough, Synchron required components that were exceptionally miniaturized, flexible, and biocompatible. Traditional manufacturing methods fell short of producing the self-expanding bioelectronic structures needed to navigate delicate neural pathways and transmit brain signals safely. Synchron needed a partner capable of transforming the impossible into reality.
The ACQUANDAS Solution
By combining precision microfabrication, monolithic fabrication, and additive Nitinol technology, ACQUANDAS delivered the enabling solution: specialized additive microfabrication of highly advanced components—paving the way for the next generation of implantable BCIs
By combining precision microfabrication, monolithic fabrication, and additive Nitinol technology, ACQUANDAS delivered the enabling solution: specialized additive microfabrication of highly advanced components—paving the way for the next generation of implantable BCIs
By combining precision microfabrication, monolithic fabrication, and additive Nitinol technology, ACQUANDAS delivered the enabling solution: specialized additive microfabrication of highly advanced components—paving the way for the next generation of implantable BCIs
Advanced Materials
We utilized Nitinol for its critical self-expandlable super elasticity and biocompatibility properties.
High-Resolution Processing
Using proprietary thin-film deposition, UV lithography, and microscale patterning, ACQUANDAS enabled the fabrication of the Stentrode™—a monolithic, self-expandable and biocompatible device equipped with electrode arrays featuring sub-micron precision.
Collaborative Scaling
We partnered with Synchron from rapid prototyping to scalable, quality-controlled production readiness.
ACQUANDAS provided the essential hardware for Synchron's innovative BCI,
turning a visionary concept into a tangible solution.
"At Synchron, we rely on partners who meet the highest standards of precision, quality, and innovation — ACQUANDAS has consistently delivered on all fronts. Their thin film components are not just enabling our engineering milestones, they are pushing the boundaries of what’s possible in neural interface technology. As we develop life-changing medical devices, ACQUANDAS's reliability and technical leadership ensure we can build with confidence and scale with speed."
ACQUANDAS provided the essential hardware for Synchron's innovative BCI,
turning a visionary concept into a tangible solution.
"At Synchron, we rely on partners who meet the highest standards of precision, quality, and innovation — ACQUANDAS has consistently delivered on all fronts. Their thin film components are not just enabling our engineering milestones, they are pushing the boundaries of what’s possible in neural interface technology. As we develop life-changing medical devices, ACQUANDAS's reliability and technical leadership ensure we can build with confidence and scale with speed."
ACQUANDAS provided the essential hardware for Synchron's innovative BCI,
turning a visionary concept into a tangible solution.
"At Synchron, we rely on partners who meet the highest standards of precision, quality, and innovation — ACQUANDAS has consistently delivered on all fronts. Their thin film components are not just enabling our engineering milestones, they are pushing the boundaries of what’s possible in neural interface technology. As we develop life-changing medical devices, ACQUANDAS's reliability and technical leadership ensure we can build with confidence and scale with speed."
Tom Oxley, Synchron CEO
Tom Oxley, Synchron CEO
Tom Oxley, Synchron CEO
The Results
This success reinforces ACQUANDAS’s position as a leading contract manufacturer in MedTech microfabrication—and has driven the expansion of our facilities and capabilities to better serve our partners.
This success reinforces ACQUANDAS’s position as a leading contract manufacturer in MedTech microfabrication—and has driven the expansion of our facilities and capabilities to better serve our partners.
This success reinforces ACQUANDAS’s position as a leading contract manufacturer in MedTech microfabrication—and has driven the expansion of our facilities and capabilities to better serve our partners.
Strategic Partnership
Synchron's 2024 equity investment in ACQUANDAS underscores the critical nature of our technology and secures their supply chain.
Strategic Partnership
Synchron's 2024 equity investment in ACQUANDAS underscores the critical nature of our technology and secures their supply chain.
Strategic Partnership
Synchron's 2024 equity investment in ACQUANDAS underscores the critical nature of our technology and secures their supply chain.
Strategic Partnership
Synchron's 2024 equity investment in ACQUANDAS underscores the critical nature of our technology and secures their supply chain.
Market Capability & Valuation
This success affirms ACQUANDAS's leadership in MedTech microfabrication and has spurred our own facility and capability expansion.
Market Capability & Valuation
This success affirms ACQUANDAS's leadership in MedTech microfabrication and has spurred our own facility and capability expansion.
Market Capability & Valuation
This success affirms ACQUANDAS's leadership in MedTech microfabrication and has spurred our own facility and capability expansion.
Market Capability & Valuation
This success affirms ACQUANDAS's leadership in MedTech microfabrication and has spurred our own facility and capability expansion.
Advancing Neurotechnology
Together, we are redefining possibilities in brain-computer interfaces, offering profound potential for patients worldwide.
Advancing Neurotechnology
Together, we are redefining possibilities in brain-computer interfaces, offering profound potential for patients worldwide.
Advancing Neurotechnology
Together, we are redefining possibilities in brain-computer interfaces, offering profound potential for patients worldwide.
Advancing Neurotechnology
Together, we are redefining possibilities in brain-computer interfaces, offering profound potential for patients worldwide.
Unlock Nitinol Insights
Download our exclusive “Breakthorugh Guide to Thin-Film Nitinol” and discover how ACQUANDAS is revolutionizing medical device miniaturization.
Unlock Nitinol Insights
Download our exclusive “Breakthorugh Guide to Thin-Film Nitinol” and discover how ACQUANDAS is revolutionizing medical device miniaturization.
Unlock Nitinol Insights
Download our exclusive “Breakthorugh Guide to Thin-Film Nitinol” and discover how ACQUANDAS is revolutionizing medical device miniaturization.
Unlock Nitinol Insights
Download our exclusive “Breakthorugh Guide to Thin-Film Nitinol” and discover how ACQUANDAS is revolutionizing medical device miniaturization.
Tailoring possibility into Perfection. Advanced microfabrication for next-generation components and devices.
Contact Us
Kaiserstraße 2, 24143
Kiel, Germany
Building F, 1st floor
Room F-021a
Ready to Innovate?
Book a free consultation to discuss your project needs.
Tailoring possibility into Perfection. Advanced microfabrication for next-generation components and devices.
Contact Us
Kaiserstraße 2, 24143, Kiel, Germany
Building F, 1st floor room F-021a
Ready to Innovate?
Book a free consultation to discuss your project needs.
Tailoring possibility into Perfection. Advanced microfabrication for next-generation components and devices.
Contact Us
Kaiserstraße 2, 24143, Kiel, Germany
Building F, 1st floor room F-021a
Ready to Innovate?
Book a free consultation to discuss your project needs.
Tailoring possibility into Perfection. Advanced microfabrication for next-generation components and devices.
Contact Us
Kaiserstraße 2, 24143, Kiel, Germany
Building F, 1st floor room F-021a
Ready to Innovate?
Book a free consultation to discuss your project needs.